Stephen Gottschalk

Human Epidermal Growth Factor Receptor 2 (HER2) –Specific Chimeric Antigen Receptor–Modified T Cells for the Immunotherapy of HER2-Positive Sarcoma

Nabil Ahmed, Vita S. Brawley, Meenakshi Hegde et al. · Journal of Clinical Oncology · 2015 · 979 citations

Medicine, Immunology, Oncology +17

HER2-Specific Chimeric Antigen Receptor–Modified Virus-Specific T Cells for Progressive Glioblastoma

Nabil Ahmed, Vita S. Brawley, Meenakshi Hegde et al. · JAMA Oncology · 2017 · 837 citations · Full text

Medicine, Immunology, Oncology +17

Tandem CAR T cells targeting HER2 and IL13Rα2 mitigate tumor antigen escape

Meenakshi Hegde, Malini Mukherjee, Zakaria Grada et al. · Journal of Clinical Investigation · 2016 · 672 citations · Full text

Medicine, Cancer Biology, Oncology +17

Sustained Complete Responses in Patients With Lymphoma Receiving Autologous Cytotoxic T Lymphocytes Targeting Epstein-Barr Virus Latent Membrane Proteins

Catherine M. Bollard, Stephen Gottschalk, Vicky Torrano et al. · Journal of Clinical Oncology · 2013 · 502 citations

Life Sciences, Immunology, Oncology +17

TanCAR: A Novel Bispecific Chimeric Antigen Receptor for Cancer Immunotherapy

Zakaria Grada, Meenakshi Hegde, Tiara T. Byrd et al. · Molecular Therapy — Nucleic Acids · 2013 · 458 citations · Full text

Medicine, Cancer Biology, Oncology +14